Korean Health Education Information and Research Center
Korean Health Education Information and Research Center was paid $2.02M by Medicaid between Jan 2018 and Dec 2024, across 167 billing codes. Its largest line is T1015, a visit at a community health center or clinic (one all-in rate) — 95% of everything it billed.
LOS ANGELES, CA 90020
Next to other Federally Qualified Health Center (FQHC) providers in California
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Paid by month
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 112,062 | $1.20M | |
| 2019 | 139,120 | $521K | |
| 2020 | 89,164 | $292K | |
| 2021 | 105,500 | $7K | |
| 2022 | 133,952 | $115.13 | |
| 2023 | 164,451 | $355.98 | |
| 2024incomplete | 201,359 | $382.61 |
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| T1015 | A visit at a community health center or clinic (one all-in rate)Clinic visit/encounter, all-inclusive | 95% | 22,396 | 19,921 | $1.91M |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 2.4% | 184,657 | 165,062 | $49K |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 1.8% | 611 | 598 | $36K |
| 92014 | Ophthalmological services: medical examination and evaluation, comprehensive, established patient | <1% | 2,779 | 2,778 | $7K |
| 92250 | <1% | 1,612 | 1,598 | $5K | |
| 90834 | Psychotherapy session, about 45 minutesPsychotherapy, 45 minutes with patient | <1% | 512 | 282 | $4K |
| 99401 | <1% | 3,260 | 2,838 | $886.68 | |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | <1% | 11,853 | 11,838 | $758.81 |
| G0467 | Community health center visit, returning patientFederally qualified health center (fqhc) visit, established patient; a medically-necessary, face-to-face encounter (one-on-one) between an established patient and a fqhc practitioner during which time one or more fqhc services are rendered and includes a typical bundle of medicare-covered services that would be furnished per diem to a patient receiving a fqhc visit | <1% | 109 | 93 | $563.24 |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | <1% | 8,584 | 8,138 | $484.91 |
| 92004 | Ophthalmological services: medical examination and evaluation, comprehensive, new patient | <1% | 564 | 564 | $448.02 |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 4,988 | 4,947 | $355.54 |
155 more codes
| G2025 | Payment for a telehealth distant site service furnished by a rural health clinic (rhc) or federally qualified health center (fqhc) only | <1% | 152 | $311.63 |
| 92015 | Determination of refractive state | <1% | 9,085 | $254.00 |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 4,482 | $165.08 |
| 99386 | <1% | 1,781 | $135.00 | |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 606 | $128.64 |
| 90686 | <1% | 195 | $109.44 | |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 743 | $101.87 |
| 0012A | <1% | 1,270 | $92.51 | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 3,080 | $79.25 |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | <1% | 273 | $74.04 |
| 92012 | Ophthalmological services: medical examination and evaluation, intermediate, established patient | <1% | 4,158 | $67.77 |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 5,882 | $56.63 |
| 99406 | <1% | 1,161 | $41.24 | |
| 81002 | <1% | 2,636 | $37.93 | |
| 90688 | <1% | 1,459 | $32.39 | |
| 81025 | <1% | 94 | $28.00 | |
| 82962 | <1% | 10,719 | $5.94 | |
| 3075F | 0% | 8,361 | $0.00 | |
| 3044F | 0% | 13,058 | $0.00 | |
| 3008F | 0% | 135,560 | $0.00 | |
| 83036 | Hemoglobin; glycosylated (A1C) | 0% | 27,704 | $0.00 |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | 0% | 2,381 | $0.00 |
| 81001 | 0% | 14,826 | $0.00 | |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | 0% | 738 | $0.00 |
| 82607 | 0% | 1,160 | $0.00 | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 0% | 15,633 | $0.00 |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | 0% | 1,963 | $0.00 |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 0% | 10,647 | $0.00 |
| 86803 | 0% | 51 | $0.00 | |
| 84443 | Thyroid stimulating hormone (TSH) | 0% | 18,405 | $0.00 |
| 80053 | Comprehensive metabolic panel | 0% | 31,368 | $0.00 |
| 88142 | 0% | 1,999 | $0.00 | |
| 85018 | 0% | 4,148 | $0.00 | |
| 84436 | 0% | 2,422 | $0.00 | |
| 86592 | 0% | 1,755 | $0.00 | |
| 3080F | 0% | 2,989 | $0.00 | |
| 1036F | 0% | 12,397 | $0.00 | |
| 3079F | 0% | 16,435 | $0.00 | |
| 3017F | 0% | 417 | $0.00 | |
| 3048F | 0% | 1,069 | $0.00 | |
| 82043 | 0% | 1,929 | $0.00 | |
| 87086 | Culture, bacterial; quantitative colony count, urine | 0% | 174 | $0.00 |
| 85027 | 0% | 11,090 | $0.00 | |
| 3074F | 0% | 36,102 | $0.00 | |
| 3049F | 0% | 492 | $0.00 | |
| 1034F | 0% | 1,130 | $0.00 | |
| 84479 | 0% | 2,425 | $0.00 | |
| 1000F | 0% | 14,146 | $0.00 | |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | 0% | 230 | $0.00 |
| 80048 | Basic metabolic panel (calcium, ionized) | 0% | 305 | $0.00 |
| 2023F | 0% | 415 | $0.00 | |
| G8510 | Screening for depression is documented as negative, a follow-up plan is not required | 0% | 88 | $0.00 |
| 99443 | 0% | 14,371 | $0.00 | |
| 93000 | 0% | 76 | $0.00 | |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | 0% | 1,271 | $0.00 |
| 3014F | 0% | 156 | $0.00 | |
| 84153 | 0% | 506 | $0.00 | |
| 3072F | 0% | 2,189 | $0.00 | |
| 99385 | 0% | 833 | $0.00 | |
| 85652 | 0% | 88 | $0.00 | |
| 92002 | 0% | 707 | $0.00 | |
| 82746 | 0% | 642 | $0.00 | |
| 86704 | 0% | 195 | $0.00 | |
| 90674 | 0% | 263 | $0.00 | |
| 82728 | 0% | 54 | $0.00 | |
| 87480 | 0% | 305 | $0.00 | |
| 87340 | 0% | 74 | $0.00 | |
| 90480 | 0% | 43 | $0.00 | |
| 87510 | 0% | 305 | $0.00 | |
| 84154 | 0% | 13 | $0.00 | |
| 91301 | 0% | 3,137 | $0.00 | |
| 86762 | 0% | 184 | $0.00 | |
| 3061F | 0% | 13 | $0.00 | |
| 97610 | 0% | 95 | $0.00 | |
| 86706 | 0% | 127 | $0.00 | |
| 97124 | 0% | 95 | $0.00 | |
| 83550 | 0% | 76 | $0.00 | |
| 90619 | 0% | 113 | $0.00 | |
| 90651 | 0% | 124 | $0.00 | |
| 96127 | 0% | 82 | $0.00 | |
| 86021 | 0% | 15 | $0.00 | |
| 97016 | 0% | 95 | $0.00 | |
| 4010F | 0% | 29 | $0.00 | |
| 86317 | 0% | 54 | $0.00 | |
| 96161 | 0% | 56 | $0.00 | |
| 90680 | 0% | 12 | $0.00 | |
| 90677 | 0% | 42 | $0.00 | |
| 84703 | 0% | 28 | $0.00 | |
| 94760 | 0% | 60 | $0.00 | |
| 0031A | 0% | 123 | $0.00 | |
| 97802 | 0% | 18 | $0.00 | |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | 0% | 19 | $0.00 |
| 86140 | 0% | 39 | $0.00 | |
| 90723 | 0% | 12 | $0.00 | |
| 0011A | 0% | 1,861 | $0.00 | |
| 82270 | 0% | 38 | $0.00 | |
| 3052F | 0% | 27 | $0.00 | |
| 81528 | Oncology (colorectal) screening, quantitative real-time target and signal amplification | 0% | 28 | $0.00 |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 0% | 27 | $0.00 |
| 91303 | 0% | 123 | $0.00 | |
| 3078F | 0% | 32,704 | $0.00 | |
| 88175 | Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer | 0% | 2,940 | $0.00 |
| 80061 | Lipid panel | 0% | 27,707 | $0.00 |
| 3077F | 0% | 8,294 | $0.00 | |
| 3725F | 0% | 122,373 | $0.00 | |
| 80074 | 0% | 10,822 | $0.00 | |
| 86703 | 0% | 6,671 | $0.00 | |
| 86480 | 0% | 832 | $0.00 | |
| G8483 | Influenza immunization was not administered for reasons documented by clinician (e.g., patient allergy or other medical reasons, patient declined or other patient reasons, vaccine not available or other system reasons) | 0% | 328 | $0.00 |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 0% | 99 | $0.00 |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 0% | 3,199 | $0.00 |
| 99499 | 0% | 655 | $0.00 | |
| 97811 | 0% | 1,359 | $0.00 | |
| 80076 | 0% | 1,178 | $0.00 | |
| 99442 | 0% | 2,724 | $0.00 | |
| 85007 | 0% | 185 | $0.00 | |
| 3046F | 0% | 155 | $0.00 | |
| 87634 | 0% | 303 | $0.00 | |
| 82274 | 0% | 2,156 | $0.00 | |
| 3050F | 0% | 371 | $0.00 | |
| 82652 | 0% | 290 | $0.00 | |
| 86735 | 0% | 184 | $0.00 | |
| 83013 | 0% | 992 | $0.00 | |
| 90661 | 0% | 1,423 | $0.00 | |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 0% | 294 | $0.00 |
| 97810 | 0% | 1,367 | $0.00 | |
| 87660 | 0% | 305 | $0.00 | |
| 87338 | 0% | 167 | $0.00 | |
| 97039 | 0% | 95 | $0.00 | |
| 90472 | Immunization administration, each additional vaccine (list separately) | 0% | 542 | $0.00 |
| 2028F | 0% | 202 | $0.00 | |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 0% | 359 | $0.00 |
| 96160 | 0% | 89 | $0.00 | |
| 3015F | 0% | 247 | $0.00 | |
| 3051F | 0% | 359 | $0.00 | |
| 2022F | 0% | 101 | $0.00 | |
| 82627 | 0% | 12 | $0.00 | |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 0% | 74 | $0.00 |
| 84460 | 0% | 25 | $0.00 | |
| 86003 | 0% | 105 | $0.00 | |
| 86787 | 0% | 167 | $0.00 | |
| 99188 | 0% | 63 | $0.00 | |
| 90633 | 0% | 64 | $0.00 | |
| 86765 | 0% | 184 | $0.00 | |
| 3045F | 0% | 27 | $0.00 | |
| 83540 | 0% | 74 | $0.00 | |
| 0502F | 0% | 25 | $0.00 | |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 0% | 13 | $0.00 |
| 90670 | 0% | 25 | $0.00 | |
| 83655 | 0% | 27 | $0.00 | |
| 85610 | 0% | 13 | $0.00 | |
| 99397 | 0% | 26 | $0.00 | |
| 90648 | 0% | 29 | $0.00 | |
| 86696 | 0% | 15 | $0.00 | |
| 82570 | 0% | 13 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
Who's on the registration
| Provider | Location | Paid |
|---|---|---|
| Korean Health, Education, Information and Research Center | Los Angeles, CA | $52.93M |
| Kheir Adult Day Health Care Center - Vermont | Los Angeles, CA | $12.04M |
| Kheir Mirae Adult Day Health Care Center | Los Angeles, CA | $1.34M |
| Korean Health, Education, Information and Research Center | Los Angeles, CA | $104.72 |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.